Chelators whose affinity for calcium is decreased by illumination
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C07C-101/26
C07D-215/38
출원번호
US-0648536
(1984-09-07)
발명자
/ 주소
Tsien Roger Y. (Berkeley CA) Grynkiewicz Grzegorz (Warszawa CA PLX) Minta Akwasi (Albany CA)
출원인 / 주소
The Regents of the University of California (Berkeley CA 02)
인용정보
피인용 횟수 :
10인용 특허 :
0
초록▼
The present invention discloses a group of calcium chelating compounds which have a descreased affinity for calcium following illumination. These new compounds contain a photolabile nitrobenzyl derivative coupled to a tetracarboxylate Ca2+chelating parent compound having the octacoordinate chelating
The present invention discloses a group of calcium chelating compounds which have a descreased affinity for calcium following illumination. These new compounds contain a photolabile nitrobenzyl derivative coupled to a tetracarboxylate Ca2+chelating parent compound having the octacoordinate chelating groups characteristic of EGTA or BAPTA. In a first form, the new compounds are comprised of a BAPTA-like chelator coupled to a single 2-nitrobenzyl derivative, which in turn is a photochemical precursor of a 2-nitrosobenzophenone. In a second form, the new compounds are comprised of a BAPTA-like chelator coupled to two 2-nitrobenzyl derivatives, themselves photochemical prcursors of the related 2-nitrosobenzophenones. The present invention also discloses a novel method for preparing 1-hydroxy- or 1-alkoxy-1-(2-nitroaryl)-1-aryl methanes. Methanes of this type are critical to the preparation of, or actually constitute, the photolabile Ca2+chelating compounds disclosed and claimed herein.
대표청구항▼
A chemical compound having the general formula: [Figure] and the pharmaceutically acceptable non-toxic salts and esters thereof wherein: A is -NO2 or -H; R3, R4 and R5 are independently -H, OH, NR6R7, or alkoxy, or R3 and R4 together are -OCH2O-or -OCH2CH2O-and R5 is -H, OH, NR6R7, or alkoxy, or R4
A chemical compound having the general formula: [Figure] and the pharmaceutically acceptable non-toxic salts and esters thereof wherein: A is -NO2 or -H; R3, R4 and R5 are independently -H, OH, NR6R7, or alkoxy, or R3 and R4 together are -OCH2O-or -OCH2CH2O-and R5 is -H, OH, NR6R7, or alkoxy, or R4 and R5 together are -OCH2O-or -OCH2CH2O-and R3 is -H, OH, NR6R7, or alkoxy; X is selected from the group comprised of -OH, alkoxy, -Cl, -Br, -NR6R7, -OCOCH3, -OCOCF3, -OCOCH2NH2, -OPO3H, and -OSO2CH3; R6 and R7 are independently -H, methyl or ethyl; D is O, N, NH, or N alkyl; Q is a double bond when D is N and a single bond otherwise; R8 is H and R9 is H or R8 and R9, togehter with heteroatom D, the carbon adjacent to R8, and the phenyl ring adjacent to R9, form quinoline ring system (D〓N, Q〓double bond); and W is -H, -OH, or NHR6, or alkoxy.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허를 인용한 특허 (10)
Tsien Roger Y. (La Jolla CA) Adams Stephen R. (Poway CA), Azide-containing chelators whose affinity for calcium ion is decreased by illumination.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.